CJC-1295 (NO DAC) / IPA

CJC No-DAC/Ipa is a multi-compound research formulation combining CJC-1295 without DAC (Mod-GRF 1-29), a synthetic 29-residue GHRH analogue, with Ipamorelin, a selective pentapeptide growth hormone secretagogue, that has been the subject of research into growth hormone-releasing hormone receptor signaling, ghrelin/GHS-receptor activation, and somatotroph pathway dynamics. Published studies have investigated the roles of these components in pituitary secretagogue models, receptor-binding characterization, and neuroendocrine regulation in preclinical research. Together they are among the more frequently referenced GH-axis peptides paired in growth-factor and endocrine research literature. This formulation is supplied as a 1:1 blend by mass, split evenly between CJC-1295 (No DAC) and Ipamorelin (5 mg + 5 mg at 10 mg; 10 mg + 10 mg at 20 mg).